Tonix Pharmaceuticals Holding (TNXP) Net Cash Flow (2010 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Net Cash Flow of -$23.8 million for Q1 2026, down 172.25% year-over-year from $32.9 million in Q1 2025, and down 228.87% quarter-over-quarter from $18.5 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Net Cash Flow (2010 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Net Cash Flow history runs 17 years deep, the most recent figure standing at -$23.8 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 172.25% year-over-year to -$23.8 million; the TTM figure through Mar 2026 stood at $53.4 million (down 57.16% YoY), while the FY2025 annual figure was $110.2 million, up 49.21% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$23.8 million, down from $18.5 million in the prior quarter.
- The five-year high for Net Cash Flow was $70.5 million in Q4 2024, with the low at -$48.2 million in Q1 2023.
- The 5-year median for Net Cash Flow is -$6.4 million (2025), against an average of $427529.4.
- Peak annual rise in Net Cash Flow reached 2318.45% in 2022, while the deepest fall reached 359.14% in 2022.
- Tonix Pharmaceuticals Holding's Net Cash Flow stood at -$19.7 million in 2022, then surged by 190.88% to $17.9 million in 2023, then surged by 293.03% to $70.5 million in 2024, then plunged by 73.81% to $18.5 million in 2025, then sank by 228.87% to -$23.8 million in 2026.
- Business Quant data shows TNXP's Net Cash Flow at -$23.8 million in Q1 2026, $18.5 million in Q4 2025, and $65.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | -9.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.33 Mn |
| Jun 30, 2026 | -9.33 Mn |
| Mar 31, 2026 | -23.81 Mn |
| Mar 31, 2026 | -23.81 Mn |
| Dec 31, 2025 | 18.47 Mn |
| Dec 31, 2025 | 18.47 Mn |
| Sep 30, 2025 | 65.12 Mn |
| Sep 30, 2025 | 65.12 Mn |
| Jun 30, 2025 | -6.38 Mn |
| Jun 30, 2025 | -6.38 Mn |
| Mar 31, 2025 | 32.95 Mn |
| Mar 31, 2025 | 32.95 Mn |
| Dec 31, 2024 | 70.52 Mn |
| Dec 31, 2024 | 70.52 Mn |
| Sep 30, 2024 | 24.10 Mn |
| Sep 30, 2024 | 24.10 Mn |
| Jun 30, 2024 | -2.89 Mn |
| Jun 30, 2024 | -2.89 Mn |
| Mar 31, 2024 | -17.90 Mn |
| Mar 31, 2024 | -17.90 Mn |